Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (DEFICIT) (Details 1)

v3.19.2
STOCKHOLDERS' EQUITY (DEFICIT) (Details 1)
6 Months Ended
Jun. 30, 2019
$ / shares
shares
Equity [Abstract]  
Number of options outstanding, beginning | shares 959,375
Number of options granted | shares 7,425,000
Number of options outstanding, ending | shares 5,684,375
Number of options exercisable | shares 3,899,225
Weighted average exercise price outstanding, beginning | $ / shares $ .41
Weighted average exercise price granted | $ / shares .19
Weighted average exercise price outstanding, ending | $ / shares 0.24
Weighted average exercise price, exercisable | $ / shares $ 0.29
Weighted average remaining contractual life outstanding, beginning 8 years 9 months 14 days
Weighted average remaining contractual life granted 8 years 6 months 10 days
Weighted average remaining contractual life outstanding, ending 8 years 18 days
Weighted average remaining contractual life exercisable 7 years 5 months 8 days